1. Home
  2. SKYT vs NVCR Comparison

SKYT vs NVCR Comparison

Compare SKYT & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SkyWater Technology Inc.

SKYT

SkyWater Technology Inc.

HOLD

Current Price

$30.28

Market Cap

1.4B

Sector

Technology

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$11.85

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SKYT
NVCR
Founded
1991
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Semiconductors
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
SKYT
NVCR
Price
$30.28
$11.85
Analyst Decision
Buy
Buy
Analyst Count
5
6
Target Price
$26.50
$28.08
AVG Volume (30 Days)
1.1M
964.3K
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
1842.86
21.79
EPS
2.44
N/A
Revenue
$442,139,000.00
$655,353,000.00
Revenue This Year
$40.16
$7.72
Revenue Next Year
$4.52
$6.74
P/E Ratio
$12.74
N/A
Revenue Growth
29.18
8.28
52 Week Low
$6.99
$9.82
52 Week High
$36.07
$20.05

Technical Indicators

Market Signals
Indicator
SKYT
NVCR
Relative Strength Index (RSI) 47.37 48.89
Support Level $29.80 $10.72
Resistance Level $31.19 $13.30
Average True Range (ATR) 1.18 0.58
MACD -0.14 0.05
Stochastic Oscillator 34.42 52.35

Price Performance

Historical Comparison
SKYT
NVCR

About SKYT SkyWater Technology Inc.

SkyWater Technology Inc is a U.S.-based, independent, pure-play technology foundry that offers semiconductor development and manufacturing services from its fabrication facilities. In its technology as a service model, it leverages a foundation of proprietary technology, engineering to co-develop process technology intellectual property (IP) with its customers that enable disruptive concepts through its Technology Services for diverse microelectronics (integrated circuits) and related micro- and nanotechnology applications. It focuses on serving diversified, high-growth, end users in numerous vertical markets, including computation, aerospace and defense (A&D), automotive and transportation, bio-health, and industrial.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: